Celularity Inc. Increase (Decrease) in Deferred Revenue
Celularity Inc. (CELU) reported Increase (Decrease) in Deferred Revenue of $425.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2023-03-31
- Celularity Inc. increase (decrease) in deferred revenue for the quarter ending 2021-12-31 was $251.00K.
- Celularity Inc. increase (decrease) in deferred revenue for the quarter ending 2020-12-31 was -$1.22M.
- Celularity Inc. increase (decrease) in deferred revenue for fiscal 2022 was $425.00K.
- Celularity Inc. increase (decrease) in deferred revenue for fiscal 2021 was -$8.38M, a 304.79% decline from fiscal 2020.
- Celularity Inc. increase (decrease) in deferred revenue for fiscal 2020 was $4.09M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|
| 2022-12-31 | $425.00K 10-K · filed 2023-03-31 | ||
| 2021-12-31 | $251.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$8.38M 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$8.63M 10-Q · filed 2021-11-12 | ||
| 2020-12-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $4.09M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $5.31M 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |